# OnCo record paq-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/paq-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "paq-therapeutics" ;
  schema:name "PAQ Therapeutics"@en ;
  schema:description "PAQ Therapeutics makes medicines that get the cell to destroy the faulty KRAS protein that drives many bowel, pancreatic and lung cancers, rather than simply blocking it."@en ;
  schema:url <https://onco.cc/companies/paq-therapeutics/>, <https://www.paqtx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.paqtx.com/>, <https://www.paqtx.com/news/paq-therapeutics-announces-39-million-series-b-financing-and-initiates-phase-1-trial-to-advance-novel-approach-addressing-kras-driven-cancers-with-high-unmet-need/>, <https://clinicaltrials.gov/study/NCT06797336>, <https://clinicaltrials.gov/study/NCT07300150> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/>, <https://onco.cc/technologies/kras-inhibitors/> ;
  onco:targets <https://onco.cc/targets/kras/> .